WO2024254612A3 - An ultrasound-activated ultrasound contrast agent - Google Patents

An ultrasound-activated ultrasound contrast agent Download PDF

Info

Publication number
WO2024254612A3
WO2024254612A3 PCT/US2024/033302 US2024033302W WO2024254612A3 WO 2024254612 A3 WO2024254612 A3 WO 2024254612A3 US 2024033302 W US2024033302 W US 2024033302W WO 2024254612 A3 WO2024254612 A3 WO 2024254612A3
Authority
WO
WIPO (PCT)
Prior art keywords
ultrasound
contrast agent
activated
sterilized
amino groups
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2024/033302
Other languages
French (fr)
Other versions
WO2024254612A2 (en
Inventor
Travis J. Williams
Jesse Tong-Pin Yen
Van Khanh DO
Andy Yu-How CHANG
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Childrens Hospital Los Angeles
University of Southern California USC
Original Assignee
Childrens Hospital Los Angeles
University of Southern California USC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Hospital Los Angeles, University of Southern California USC filed Critical Childrens Hospital Los Angeles
Publication of WO2024254612A2 publication Critical patent/WO2024254612A2/en
Publication of WO2024254612A3 publication Critical patent/WO2024254612A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/22Echographic preparations; Ultrasonic imaging preparations
    • A61K49/222Echographic preparations; Ultrasonic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223Microbubbles, hollow microspheres, free gas bubbles, gas microspheres
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/48Diagnostic techniques
    • A61B8/481Diagnostic techniques involving the use of contrast agents, e.g. microbubbles introduced into the bloodstream
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/0004Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Acoustics & Sound (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

An ultrasound-activated ultrasound contrast agent includes a sterilized liquid carrier; and a sterilized polymer dispersed and/or dissolved in the sterilized liquid carrier. Advantageously, the sterilized polymer includes amino groups that are at least partially functionalized with CO2 at a plurality of the amino groups.
PCT/US2024/033302 2023-06-09 2024-06-10 An ultrasound-activated ultrasound contrast agent Ceased WO2024254612A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202363471994P 2023-06-09 2023-06-09
US63/471,994 2023-06-09

Publications (2)

Publication Number Publication Date
WO2024254612A2 WO2024254612A2 (en) 2024-12-12
WO2024254612A3 true WO2024254612A3 (en) 2025-05-08

Family

ID=93796432

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2024/033302 Ceased WO2024254612A2 (en) 2023-06-09 2024-06-10 An ultrasound-activated ultrasound contrast agent

Country Status (1)

Country Link
WO (1) WO2024254612A2 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1232837A (en) * 1983-04-15 1988-02-16 Jurgen Hilmann Ultrasound contrast agent containing microparticles and gas micro-bubbles

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1232837A (en) * 1983-04-15 1988-02-16 Jurgen Hilmann Ultrasound contrast agent containing microparticles and gas micro-bubbles

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
CHANG ANDY Y, SYED HELAL, NUSSBAUM ZOE, DO VAN, WILLIAMS TRAVIS J, YEN JESSE T: "Selective release of CO2-loaded nanoparticles for vesicoureteral reflux imaging", PEDIATRIC UROLOGY FALL CONGRESS, SOCIETY FOR PEDIATRIC UROLOGY, US, 21 September 2023 (2023-09-21), US, pages 1 - 2, XP093311827, Retrieved from the Internet <URL:https://fallcongress.spuonline.org/program/2023/53.cgi> *
HAN XIANGJUN, XU KE, TARATULA OLENA, FARSAD KHASHAYAR: "Applications of nanoparticles in biomedical imaging", NANOSCALE, vol. 11, no. 3, 17 January 2019 (2019-01-17), UK, pages 799 - 819, XP093311821, ISSN: 2040-3364, DOI: 10.1039/C8NR07769J *
LUO WENLI, LI ZHAOJIAN, ZHANG LING, XIE XINGYI: "Polyethylenimine-CO2 adduct templated CaCO3 nanoparticles as anticancer drug carrier", CANCER NANOTECHNOLOGY, vol. 14, no. 7, 1 December 2023 (2023-12-01), AT, pages 1 - 21, XP093311789, ISSN: 1868-6958, DOI: 10.1186/s12645-023-00156-z *
ZHANG KUN, XU HUIXIONG, CHEN HANGRONG, JIA XIAOQING, ZHENG SHUGUANG, CAI XIAOJUN, WANG RONGHUI, MOU JUAN, ZHENG YUANYI, SHI JIANLI: "CO 2 bubbling-based 'Nanobomb' System for Targetedly Suppressing Panc-1 Pancreatic Tumor via Low Intensity Ultrasound-activated Inertial Cavitation", THERANOSTICS, vol. 5, no. 11, 12 September 2015 (2015-09-12), AU , pages 1291 - 1302, XP093311803, ISSN: 1838-7640, DOI: 10.7150/thno.12691 *
ZHAO CHONG, ZHOU BENQING: "Polyethyleneimine-Based Drug Delivery Systems for Cancer Theranostics", JOURNAL OF FUNCTIONAL BIOMATERIALS, vol. 14, no. 1, CH , pages 12 - 12-27, XP093311812, ISSN: 2079-4983, DOI: 10.3390/jfb14010012 *
ZHOU BENQING, XIONG ZUOGANG, WANG PENG, PENG CHEN, SHEN MINGWU, MIGNANI SERGE, MAJORAL JEAN-PIERRE, SHI XIANGYANG: "Targeted tumor dual mode CT/MR imaging using multifunctional polyethylenimine-entrapped gold nanoparticles loaded with gadolinium", DRUG DELIVERY, vol. 25, no. 1, 1 January 2018 (2018-01-01), US , pages 178 - 186, XP093311816, ISSN: 1071-7544, DOI: 10.1080/10717544.2017.1422299 *

Also Published As

Publication number Publication date
WO2024254612A2 (en) 2024-12-12

Similar Documents

Publication Publication Date Title
DK0458745T3 (en) Gas or air-filled polymer microballoons that can be used as suspensions in liquid carriers for ultrasonic echography
WO2020012314A3 (en) Polyethylene composition and film
WO2006004941A3 (en) Biomaterial
EA200702341A1 (en) PROPYLENE POLYMER WITH A HIGH DEGREE OF CRYSTALLITY
WO2008109098A3 (en) Medical devices having improved performance
EP1806386A3 (en) Associative thickener combinations
WO2005069966A3 (en) Vascular grafts with amphiphilic block copolymer coatings
ATE400306T1 (en) POLYMER PARTICLES ABSORBING BLOOD AND/OR BODY FLUID
AU7914900A (en) Polyurethanes and graft mixed polymers based on polyurethane and their use for producing coating materials, adhesives and sealing masses
WO2005051456A3 (en) Composition and apparatus for transdermal delivery
ATE502062T1 (en) AQUEOUS DISPERSIONS OF POLYTETRAFLUORETHYLENE PARTICLES
BR0303493A (en) Antibiotic / antibiotic polymer combination
WO2020012313A3 (en) Polyethylene composition and film having retained dart impact
JP2002519462A5 (en)
WO2024254612A3 (en) An ultrasound-activated ultrasound contrast agent
Correia et al. Anti-biofouling 3D porous systems: the blend effect of oxazoline-based oligomers on chitosan scaffolds
EP1862514A4 (en) Coating solution for anti-fogging treatment and fog-resistant product
AU2003213152A1 (en) Hydrolytically degradable alkylene oxide based polymers
WO2023034765A3 (en) Ultra-high molecular weight polymers and methods of using the same
PT1773399E (en) Hydrogels of hyaluronic acid and alpha, beta-polyaspartylhydrazide and their biomedical and pharmaceutical uses
WO2006016670A8 (en) Antistatic agent, antistatic film and product coated with antistatic film
ATE431387T1 (en) SOLID PIGMENT CONCENTRATES
FR3116534B1 (en) Chitosan-based beads, preparation, compositions and applications
WO2005007798A3 (en) Hydroxypropyl methacrylamide polymers and copolymers comprising reactive thiazoline-2-thione
DE60314186D1 (en) LUMINOUS SUBSTANCE OR CONTRASTANT LATEX POLYMER PARTICLES AND THE METHOD OF MANUFACTURING THE SAME

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 24820241

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE